Congress trades in Alnylam Pharmaceuticals (ALNY)
Healthcare · Biotechnology
3 members of Congress have disclosed 5 trades in Alnylam Pharmaceuticals (ALNY) since 2023: 1 buy and 4 sales. The most recent was disclosed on Sep 9, 2026.
- Trades disclosed
- 5
- Members trading
- 3
- Buys / sells
- 1 / 4
- Reported value
- $19K–$110K
Who traded ALNY
- Rep. Josh Gottheimer (D-NJ-5)1 buy · 2 sales12Feb 15, 2024
- Sen. Cory A. Booker (D-NJ)0 buys · 1 sale01Sep 9, 2026
- Rep. Jefferson Shreve (R-IN-6)0 buys · 1 sale01Jun 23, 2025
All trades
- Sep 9, 2026$1K–$15K
Sen. Cory A. Booker (D-NJ)
Sold (full) Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Aug 11, 2026 · disclosed Sep 9, 2026 · Spouse
- Jun 23, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
Sold (full) Alnylam Pharmaceuticals ALNY
$15K–$50K · Traded May 12, 2025 · disclosed Jun 23, 2025
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (full) Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Jan 29, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Jan 11, 2024 · disclosed Feb 15, 2024 · Joint
- Jan 7, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (full) Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Dec 11, 2023 · disclosed Jan 7, 2024 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.